Brind.

Natera utilizes Horizon technology for carrier screening purposes.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Natera Horizon

Keep exploring

The entities involved

Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
Horizon
News website in Hong Kong

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 8Medical Device NetworkNatera introduces prenatal test for detecting inherited conditions Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to